Future of health 5 - A long and healthy life
The fifth study in Roland Berger's Future of Health series focuses on longevity.
As life expectancy continues to rise, the pursuit of longevity has become one of the most dynamic areas in science and medicine. In this episode, Nina Ruge, host of the online platform staYoung, and our partner Thilo Kaltenbach discuss the latest breakthroughs in longevity research. They explore how repurposed medications, advanced therapies, and lifestyle choices contribute to a longer and healthier life. With a rapidly expanding market and growing scientific progress, longevity is no longer only about adding years but also about improving quality of life.
Nina and Thilo examine longevity-focused pharmaceuticals such as Metformin and Rapamycin. Originally developed for other conditions, these medications are now being studied for their potential to extend lifespan and improve health span. They also discuss innovations like epigenetic reprogramming and senolytics, which target the biological processes of aging. While these advancements hold promise, they remain in early stages and face challenges related to clinical validation and ethical considerations.
Beyond pharmaceuticals, longevity is closely linked to lifestyle. Scientific research continues to confirm the importance of regular physical activity, a balanced diet, quality sleep, and stress management in supporting healthy aging. As the longevity sector develops, combining medical innovation with proven lifestyle strategies presents one of the most effective approaches. The business opportunities in this field are growing, creating potential for individuals, companies, and investors shaping the future of longevity.
Listen to this episode on
Spotify
Listen to this episode on
Apple Podcast
Listen to this episode on
Podigee